drugset / Trial / NCT06614153
Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations
RandomizedCrossoverSingle-blindTreatment
Summary
The study is a multicenter, randomized, open-label, active-controlled, Phase II clinical study. The aim of this trial is to evaluated the pharmacokinetics, pharmacodynamics,efficacy and assessed the safety of HRG2010 compared with a sustained-release cabridopa-levodopa formulation in Parkinson's Disease Patients With Motor Fluctuations.
Timeline
- Start
- 2023-05-16
- Primary completion
- 2024-01-31
- Completion
- 2024-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbidopa | Unknown | — | Oral |
| Subject | HRG2010 | Unknown | — | Oral |
| Comparator | Levodopa | Small molecule | — | Oral |